Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Anatomical Record|January 1, 1990
Binding of the blood group-reactive lectins to human adult kidney specimensL Laitinen, H Juusela, I Virtanen
Scandinavian Journal of Urology and Nephrology|January 1, 1977
Preoperative irradiation in the treatment of renal adenocarcinomaH Juusela, K Malmio, O Alfthan, et al.
European Urology|January 1, 1992
Can fine needle aspiration biopsy detect incidental prostatic carcinoma (T1) prior to TUR?H Juusela, M Ruutu, J Permi, et al.
Annales Chirurgiae Et Gynaecologiae Fenniae|January 1, 1975
Radiology and fine needle aspiration biopsy in the diagnosis of tumours of the kidneyJ Edgren, E Taskinen, O Alfthan, et al.
Annales Chirurgiae Et Gynaecologiae. Supplementum|January 1, 1993
Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate GroupJ Aro, M Ruutu, H Juusela, et al.
Annales Chirurgiae Et Gynaecologiae|January 1, 1987
A controlled, double-blind, cross-over study of terodiline in motor urge incontinenceO Lukkarinen, P Gröhn, G Wilén-Rosenqvist, et al.
British Journal of Cancer|March 31, 1999
European randomized study of prostate cancer screening: first-year results of the Finnish trialL Määttänen, A Auvinen, U H Stenman, et al.
The American Journal of Pathology|November 1, 1992
Integrin distributions in renal cell carcinomas of various grades of malignancyM Korhonen, L Laitinen, J Ylänne, et al.
Urology|August 30, 2000
Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron networkP Finne, R Finne, A Auvinen, et al.
The Journal of Urology|September 8, 2001
Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening testsT Mäkinen, T L Tammela, M Hakama, et al.
Pageof 2